455 items related to 'SMC'
(Page 7 of 23)
-
Blog :
Top reads of 2023
In 2023, alongside continuing our work with communities and governments across Africa and Asia to strengthen health systems, improve access to health services and find solutions to improve health and…
-
completedConducting rapid assessments to build the evidence base for seasonal malaria chemoprevention in new geographies
SMC has been used successfully in the Sahel region of West and Central Africa and has been shown to be 75 percent effective in preventing uncomplicated and severe malaria during this high-risk…
-
Resources: Presentation :
Rapid assessments for the deployment of seasonal malaria chemoprevention in new geographies of East and southern Africa
A rapid assessment will estimate the effectiveness, chemoprevention efficacy, potential deployment impact, acceptability and feasibility of seasonal malaria chemoprevention using SPAQ in new…
-
Resources: Presentation :
Seasonal malaria chemoprevention effectiveness in Northern Mozambique: Results from a cluster-randomised controlled trial
After adjusting for relevant variables on an intention-to-treat basis, seasonal malaria chemoprevention with sulfadoxine-pyrimethamine plus amodiaquine effectively prevented clinical malaria in…
-
ASTMH Annual Meeting pinpoints research gaps to advance global health
In October 2023, Malaria Consortium participated in the 72nd Annual Meeting of the American Society of Tropical Medicine & Hygiene (ASMTH) in Chicago, USA. The conference brought together…
-
Showcasing our SMC research at the ASTMH Annual Meeting 2023
This year, Malaria Consortium proudly marks its 20th anniversary. Since its inception in 2003, our organisation has collaborated with governments and partners across Africa and Asia focusing on…
-
Resources: Presentation :
A cluster randomised controlled non-inferiority trial to assess the protective effectiveness of SPAQ and DP for SMC among children 3–59 months, in the context of high parasite resistance, Karamoja region
Sulfadoxine-pyrimethamine plus amodiaquine (SPAQ) and dihydroartemisinin piperaquine (DP) were both highly effective at preventing clinical malaria in eligible children during the high transmission…
-
Resources: Annual review :
20 years of impact: Saving lives, transforming communities
On this, the 20th anniversary of Malaria Consortium, we reflect on the journey so far and provide insights into what we have achieved and how we seek to address the key challenges that remain.
-
Resources: Capacity statement :
Integrated community case management
With vast experience in supporting iCCM initiatives across Africa and Asia, Malaria Consortium offers technical assistance to ministries of health to implement and improve their iCCM programmes.
-
Resources: Poster :
Resistance markers to sulfadoxine-pyrimethamine and amodiaquine in the context of seasonal malaria chemoprevention in Burkina Faso
Sulfadoxine-pyrimethamine and amodiaquine remain effective after eight years of SMC implementation in Burkina Faso.
-
Resources: Poster :
Analysing age-related trends in routine data through transmission modelling during seasonal malaria chemoprevention in Burkina Faso
Age-related variations in routine data can be attributed to non-malarial fevers and treatment-seeking behaviours, which mask the impact of seasonal malaria chemoprevention.
-
Resources: Poster :
Development and evaluation of a novel protocol to assess the efficacy of seasonal malaria chemoprevention using sulfadoxine, pyrimethamine and amodiaquine in an area of high drug resistance in Nampula, Mozambique
Seasonal malaria chemoprevention with SPAQ is preventing clinical disease but is not preventing new sub-patent infections over 28 days despite therapeutic drug levels, suggesting prevention of…
-
Resources: Poster :
The impact of seasonal malaria chemoprevention on Plasmodium falciparum resistance to sulfadoxine-pyrimethamine and amodiaquine in northern Mozambique
Monitoring resistance markers is essential as Mozambique expands seasonal malaria chemoprevention and introduces new chemoprevention strategies.
-
Resources: Poster :
The role of community distributors in ensuring the quality delivery of seasonal malaria chemoprevention in Nigeria
Directly observed treatment practised by community distributors is critical for the quality delivery of seasonal malaria chemoprevention.
-
Resources: Poster :
Assessing coverage and quality of seasonal malaria chemoprevention before and during scale-up in Uganda
Seasonal malaria chemoprevention was successfully scaled up in the Karamoja region of Uganda, a new geographical context, achieving good coverage and quality.
-
Resources: Poster :
Assessing age compliance during seasonal malaria chemoprevention in nine states in Nigeria
The administration of seasonal malaria chemoprevention medicines to age-ineligible children is common. Understanding associated causes will enhance the quality of programmes.
-
Resources: Poster :
Molecular surveillance of sulfadoxine-pyrimethamine and amodiaquine resistance markers in northeastern Uganda
Seasonal malaria chemoprevention has not notably altered sulfadoxine-pyrimethamine resistance after two consecutive annual rounds in northeastern Uganda.
-
Resources: Poster :
Community leadership in seasonal malaria chemoprevention: Engaging communities in northern Mozambique
The involvement of community leaders contributed to the high acceptability of seasonal malaria chemoprevention.
-
Resources: Poster :
Health-seeking behaviours and beliefs surrounding malaria in three East and southern African geographies introducing seasonal malaria chemoprevention: A secondary qualitative analysis
Context-specific data on health-seeking behaviours and beliefs surrounding malaria should be used to strengthen community engagement and health messaging.
-
Resources: Poster :
Quasi-experimental study to estimate the effectiveness of seasonal malaria chemoprevention in South Sudan
In South Sudan, seasonal malaria chemoprevention reduced malaria in children during the high transmission season, despite potential high levels of resistance.